These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 203395)
41. Combination chemotherapy including high dose methotrexate and radiotherapy, in the treatment of small cell carcinoma of the lung. Burdon JG; Henderson MM Clin Exp Pharmacol Physiol Suppl; 1979; 5():17-21. PubMed ID: 233814 [TBL] [Abstract][Full Text] [Related]
42. Phase II study of mitomycin in small cell lung carcinoma. McHale MS; Einhorn LH Cancer Treat Rep; 1986 May; 70(5):675. PubMed ID: 3011261 [No Abstract] [Full Text] [Related]
43. Phase II study of carboplatin in previously untreated patients with metastatic small cell lung carcinoma. Jacobs RH; Bitran JD; Deutsch M; Hoffman PC; Sinkule J; Purl S; Golomb HM Cancer Treat Rep; 1987 Mar; 71(3):311-2. PubMed ID: 3028621 [TBL] [Abstract][Full Text] [Related]
44. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer. Myers JW; Von Hoff DD; Clark GM; Coltman CA Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511 [No Abstract] [Full Text] [Related]
45. Cytarabine: an inactive drug for extensive-stage small cell lung cancer. Stuart-Harris R; Bishop J; Raghavan D; Gianoutsos P; Lee J; Hillcoat B; Fox R Cancer Treat Rep; 1986 Feb; 70(2):303-4. PubMed ID: 3004728 [No Abstract] [Full Text] [Related]
46. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer. Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029 [TBL] [Abstract][Full Text] [Related]
47. High-dose etoposide therapy for extensive small cell lung cancer: a Cancer and Leukemia Group B Study. Luikart SD; Propert KJ; Modeas CR; Green MR; Perry MC Cancer Treat Rep; 1987 May; 71(5):533-4. PubMed ID: 3032434 [TBL] [Abstract][Full Text] [Related]
48. RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group. Punt CJ; de Jonge MJ; Monfardini S; Daugaard G; Fiedler W; Baron B; Lacombe D; Fumoleau P; Eur J Cancer; 2004 Jun; 40(9):1332-4. PubMed ID: 15177492 [TBL] [Abstract][Full Text] [Related]
49. [Cisplatin, peplomycin, mitomycin C, and vincristine combination chemotherapy of non-small cell carcinoma of the lung]. Saito H; Nomura F; Kawatsu H; Sakai S; Kobayashi T; Shimokata K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2715-8. PubMed ID: 6210062 [TBL] [Abstract][Full Text] [Related]
50. Reactions to "laetrilomania". N Engl J Med; 1977 Jul; 297(4):218-21. PubMed ID: 876280 [No Abstract] [Full Text] [Related]
51. Laetrile: alleged cancer cure. Med J Aust; 1977 Jul; 2(3):76. PubMed ID: 895633 [No Abstract] [Full Text] [Related]